Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration-Reference-Cited by-同舟云学术

Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration

Published:2022-12 Issue:12 Volume:58 Page:840-842
ISSN:0300-2896
Container-title:Archivos de Bronconeumología
language:en
Short-container-title:Archivos de Bronconeumología

Author:

Parr David G.,Chorostowska-Wynimko Joanna,Corsico Angelo,Esquinas Cristina,McElvaney Gerard N.,Sark Annelot D.,Sucena Maria,Tanash Hanan,Turner Alice M.,Miravitlles Marc

Funder

European Respiratory Society

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference8 articles.

1. European Respiratory Society Statement: Diagnosis and treatment of pulmonary disease in alpha-1 antitrypsin deficiency;Miravitlles;Eur Respir J,2017

2. COVID-19 infection in severe Alpha 1-antitrypsin deficiency: looking for a rationale;Ferrarotti;Respir Med,2021

3. alpha1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action;Yang;Lancet Respir Med,2021

4. Hypothesis: alpha-1-antitrypsin is a promising treatment option for COVID-19;Bai;Med Hypotheses,2021

5. The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiency;Miravitlles;Eur Respir J,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutrophil proteases are protective against SARS-CoV-2 by degrading the spike protein and dampening virus-mediated inflammation;JCI Insight;2024-04-08

2. The Inhibition of Serine Proteases by Serpins Is Augmented by Negatively Charged Heparin: A Concise Review of Some Clinically Relevant Interactions;International Journal of Molecular Sciences;2024-02-02

3. Personalised indication of augmentation therapy for emphysema associated with severe alpha-1 antitrypsin deficiency: a case series;Therapeutic Advances in Respiratory Disease;2024-01

4. Impact of COVID-19 on patients with PiZZ alpha1-antitrypsin deficiency: the IMCA1 study revisited.;Respiratory infections and bronchiectasis;2023-09-09

5. Alpha-1-antitrypsin antagonizes COVID-19: a review of the epidemiology, molecular mechanisms, and clinical evidence;Biochemical Society Transactions;2023-06-09